Circulating platelet-leukocyte aggregates: A marker of microvascular injury in diabetic patients

Thrombosis Research

Volumn 121, Issue 6, 2008, Pages 843-848

  Elalamy, I ^a   Chakroun, T ^a   Gerotziafas, G T ^a   Petropoulou, A ^a   Robert, F ^a   Karroum, A ^a   Elgrably, F ^a   Samama, M M ^a   Hatmi, M ^a,b  

^a HÔTEL DIEU   (France)

^b INSTITUT PASTEUR   (France)

Author keywords

Diabetes; Platelet leukocyte aggregates; Retinopathy; Vascular lesions

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD VESSEL INJURY; CELL AGGREGATION; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE MARKER; FEMALE; FLOW CYTOMETRY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NEUTROPHIL; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RETINOPATHY; STATISTICAL SIGNIFICANCE; THROMBOCYTE;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD PLATELETS; CELL AGGREGATION; DIABETES MELLITUS; DIABETIC RETINOPATHY; FEMALE; HUMANS; LEUKOCYTES; MALE; MICROCIRCULATION; MIDDLE AGED; PLATELET AGGREGATION; VASCULAR DISEASES;

EID: 41949116878     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2007.07.016     Document Type: Article

References (29)

1. Lüscher T.F., Greager M.A., Beckman J.A., and Cosentino F. Diabetes and vascular disease pathophysiology, clinical consequences and medical therapy. Circulation 108 (2003) 1655-1661
2. Winer N., and Sowers J.R. Epidemiology of diabetes. J Clin Pharmacol 44 (2004) 397-405
3. Kessler L., Wiesel M.L., Attali P., Mossard J.M., Cazenave J.P., and Pinget M. von Willebrand factor in diabetic angiopathy. Diabetes Metab 24 (1998) 327-336
4. Negrean V., Suciu I., Sampelean D., and Cozma A. Rheological changes in diabetic microangiopathy. Rom J Intern Med 42 (2004) 407-413
5. Fattah M.A., Shaheen M.H., and Mahfouz M.H. Disturbances of haemostasis in diabetes mellitus. Dis Markers 19 (2004) 251-258
6. Carr M.E. Diabetes mellitus: a hypercoagulable state. J Diabetes Complications 15 (2001) 44-54
7. Sfredel V., Mota M., Traila A., Danoiu S., and Matcas H. Disturbances of the coagulating equilibrium of blood in diabetes mellitus. Rom J Intern Med 37 (1999) 251-260
8. Schram M.T., Chaturvedi N., Schalkwijk C.G., Fuller J.H., and Stehouwer C.D. Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes-the EURODIAB Prospective Complications Study. Diabetologia 48 (2005) 370-378
9. Colwell J.A., and Nesto R.W. The platelet in diabetes. Diabetes Care 26 (2003) 2181-2188
10. Cabeza N., Li Z., Schulz C., Kremmer E., Massberg S., Bültmann A., et al. Surface expression of collagen receptor Fc receptor-δ/glycoprotein VI is enhanced on platelets in type 2 diabetes and mediates release of CD40 ligand and activation of endothelial cells. Diabetes 53 (2004) 2117-2121
11. Yngen M., Ostenson C.G., Hu H., Li N., Hjemdahl P., and Wallen N.H. Enhanced P-selectin expression and increased soluble CD40 ligand in patients with type 1 diabetes mellitus and microangiopathy: evidence for platelet hyperactivity and chronic inflammation. Diabetologia 47 (2004) 537-540
12. Watala C. Blood platelet reactivity and its pharmacological modulation in people with diabetes mellitus. Curr Pharm Des 11 (2005) 2331-2365
13. Vandendries E.R., Furie B.C., and Furie B. Role of P-selectin and PSGL-1 in coagulation and thrombosis. Thromb Haemost 92 (2004) 459-466
14. Rinder H.M., Bonan J.L., Rinder C.S., Ault K.A., and Smith B.R. Activated and unactivated platelet adhesion to monocytes and neutrophils. Blood 78 (1991) 1760-1769
15. Hidari K.I., Wevrich A.S., Zimmerman G.A., and McEver R.P. Engagement of P-selectin glycoprotein ligand-1 enhances tyrosine phosphorylation and activates mitogen-activated protein kinases in human neutrophils. J Biol Chem 272 (1977) 28750-28756
16. Li N., Goodall A.H., and Hjemdahl P. Efficient flow cytometric assay for platelet-leukocyte aggregates in whole blood using fluorescence signal triggering. Cytometry 35 (1999) 154-161
17. Biondi-Zoccai G.G., Abbate A., Liuzzo G., and Biasucci L.M. Atherothrombosis, inflammation and diabetes. J Am Coll Cardiol 41 (2003) 1071-1077
18. Tschoepe D., Roesen P., Esser J., Schwippert B., Nieuwenhuis H.K., Kehel B., et al. Large platelets circulate in an activated state in diabetes mellitus. Semin Thromb Hemost 17 (1991) 433-438
19. Winocour P.D. Platelets, vascular disease and diabetes mellitus. Can J Physiol Pharmacol 72 (1994) 295-303
20. Collier A., Jackson M., Bel D., Patrick A.W., Matthews D.M., Young R.J., et al. Neutrophil activation detected by increased neutrophil elastase activity in type 1 (insulin-dependent) diabetes mellitus. Diabetes Res 10 (1989) 135-138
21. Tschoepe D., Rauch U., and Schwippert B. Platelet-leukocyte cross-talk in diabetes mellitus. Horm Metab Res 29 (1997) 631-635
22. Kaplar M., Kappelmayer J., Veszpremi A., Szabo K., and Udvardy M. The possible association of in vivo leukocyte-platelet heterophilic aggregate formation and the development of diabetic angiopathy. Platelets 12 (2001) 419-422
23. Hilberg T., Eichler E., Glaser D., Schmidt V., and Gabriel H.H. Platelet activity, reactivity and platelet-leukocyte conjugate formation before and after exhaustive or moderate exercise in patients with IDDM. Platelets 15 (2004) 101-108
24. Russel C., Dunbard P., Salisbury S., Sketris I., and Kephart G. Hypertension control: results from the Diabetes Care Program of Nova Scotia registry and impact of changing clinical practice guidelines. Cardiovasc Diabetol 11 (2005) 1-15
25. Hu. H., Li N., Yngen M., Ostenson C.G., Wallen N.H., and Hjemdahl P. Enhanced leukocyte-platelet cross talk in type 1 diabetes mellitus: relationship to microangiopathy. J Thromb Haemost 2 (2004) 58-64
26. Zumbach M., Hofmann M., Borcea V., Luther T., Kotzsch M., Muller M., et al. Tissue factor antigen is enhanced in patients with microvascular complications of diabetes mellitus. Exp Clin Endocrinol Diabetes 105 (1997) 204-206
27. Sambola A., Osende J., Hathcock J., Degen M., Nemerson Y., Fuster V., et al. Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity. Circulation 25 (2003) 973-977
28. Reverter J.L., Reverter J.C., Tassies D., Rius F., Monteagudo J., Rubies-Prat J., et al. Thrombomodulin and induced tissue factor expression on monocytes as markers of diabetic microangiopathy: a prospective study on hemostasis and lipoprotein in insulin-dependent diabetes mellitus. Am J Hematol 56 (1997) 93-99
29. Barnard M.R., Linden M.D., Frelinger A.L., Li Y., Fox M.L., Furman M.I., et al. Effects of platelet binding on whole blood flow cytometry assays of monocyte and neutrophil procoagulant activity. J Thromb Haemost 3 (2004) 2563-2570